METHOD OF TREATMENT OF NEURODEGENERATIVE DISORDERS USING PENTAAZA-MACROCYCLIC LIGAND COMPLEXES - Patent 1353655

(19)

(11)

EP 1 353 655 A2

(12)

(88)	Date of publication A3:
	06.02.2003

(43)	Date of publication:
	22.10.2003 Bulletin 2003/43

(21)	Application number: 02703228.3

(22)	Date of filing: 23.01.2002

(51)	International Patent Classification (IPC)⁷: A61K 31/00, A61K 31/555, A61P 25/28

(86)	International application number:
	PCT/US0202/108

(87)	International publication number:
	WO 0205/8686 (01.08.2002 Gazette 2002/31)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

26.01.2001 US 264493 P

(71)	Applicant: Metaphore Pharmaceuticals Inc.
	St. Louis, MO 63114 (US)

(72)	Inventors:
	SALVEMINI, Daniela Chesterfield, MO 63017 (US) RILEY, Dennis, P. Chesterfield, MO 63017 (US)

(74)	Representative: Eyles, Christopher Thomas
	W.P. THOMPSON & CO.55 Drury Lane London WC2B 5SQ London WC2B 5SQ (GB)

(54)	METHOD OF TREATMENT OF NEURODEGENERATIVE DISORDERS USING PENTAAZA-MACROCYCLIC LIGAND COMPLEXES